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Background: Millions of people undergo non-cardiac surgery annually, but there are few large scale studies examining the epidemiology and 
impact of post-operative atrial fibrillation (POAF) in this population.
Methods: We analyzed administrative data collected from patients aged 18 and older who underwent major non-cardiac surgery (defined by a 
mean hospitalization of 3 days or more) at 375 US hospitals between January 1, 2008 and December 31, 2008. Clinically significant POAF was 
defined as atrial fibrillation (coded during hospitalization) that necessitated therapy in the post-operative period. ‘Condition present on admission’ 
(CPOA) coding was available for all cases of POAF.
Results: Of 370,447 patients, 10,968 (3.0%) developed clinically significant POAF. Patients developing POAF were older (74.6 years vs. 62.4 years, 
P<.001) and more likely to have heart failure (30.5% vs. 7.0%, P<.001). Atrial fibrillation was coded as ‘present on admission’ in 67.7% of POAF 
patients. POAF patients had markedly longer length of stay, higher costs, and higher mortality, but similar re-admission rate (Table 1). These findings 
did not differ by CPOA code.
Conclusion: POAF requiring therapy, as a complication of non-cardiac surgery, is associated with far higher mortality and cost regardless of 
whether or not atrial fibrillation is a pre-existing co-morbidity. Managing atrial fibrillation prior to surgery and identifying those at risk for developing 
POAF may represent new strategies to reduce peri-operative risk.
Table 1: Outcomes of patients with and without post-operative atrial fibrillation (POAF)
Outcomes
AF
(N= 10968)
No AF
(N=359479)
*
Adjusted Odds Ratio
(or Adjusted Mean DIfference),
[95% CI],
p-value
Mortality 1549 (14.1%) 7402 (2.1%)
1.74
[1.62-1.86],
p<0.001
Re-admission 30 days 1586 (14.4%) 35419 (9.8%)
1.00
[0.94-1.06],
p = 0.999
Mean Length of Stay (SD) § 15.0 (14.0) 6.9 (8.3)
2.36 days
[2.23-2.50],
p<0.001
Mean Hospitalization Cost (SD) ¶ $25592 (13090) $17350 (10424)
$4169
[$3974-$4364],
p<0.001
* All unadjusted comparisons have p < 0.001
§ Length of stay in days
¶ top 5th percentile of cost truncated to reduce skewness
